Anthrax Toxin: History and Recent Advances and Perspectives

References

• Graham-Smith G. S. Flies in relation to disease: non blood sucking flies 180–209. Cambridge University Press, Cambridge 1913
   Google Scholar
• Mitzmain M. B. Experimental insect transmission of anthrax Public Health Rep. 1914; 29: 75
   Google Scholar
• Morris H. Some carriers of anthrax infection. J. Am Vet. Med. Assoc. 1920; 56: 606
   Google Scholar
• Davies J. C. A. A major epidemic of anthrax in Zimbabwe II Distribution of cutaneous lesions Cent. Afr. J. Med. 1983; 29: 8
   Google Scholar
• McKendrick D. R. A. Anthrax and its transmission to humans Cent. Afr. J. Med. 1980; 26: 126
   Google Scholar
• Turner M. Anthrax in Humans in Zimbabwe. Central African Journal of Med. 1980; 26(7)161
   PubMedGoogle Scholar
• Turell M. J., Knudson G. B. Mechanical Transmission of Bacillus anthracis by Stable Flies (Stomoxys calcitrans) and Mosquitoes(Aedes aegypti and Aedes taeniorhynchus). Infect Immun. 1987; 55: 1859
   PubMed Web of Science ®Google Scholar
• Stephen J. Anthrax toxin. Pharmacol. Ther. 1981; 12: 501
   PubMed Web of Science ®Google Scholar
• Hedlund K. Bacterial Toxins. Handbook of Natural Toxins, M Hardegree, T U Anthony. Marcel Dekker, Inc., New York 1988; Vol 4: 371
   Google Scholar
• Tigertt W. D. Anthrax, J. Hyg. 1980; 85: 415
   PubMedGoogle Scholar
• Pasteur L. De patte nuation des virus et de leur rotour a la virulence. C. R. Acad. Sci. Agric. Bulg. 1881; 92: 429
   Google Scholar
• Ginsburg N. N., Cherkasskiy B. L. Basic results in control of anthrax in USSR. Vestniki Akademii Nauk SSR 1967; 23: 61
   Google Scholar
• Gefen N. Investigation of the reactogenicity, harmlessness and immunologic effectiveness of the aerosol method of immunization against anthrax in tests of human beings. Zh. Microbiol. Epidemiol. Immunobiol. 1969; 12: 81
   Google Scholar
• Burgasov P. N., Cherkasskiy B. L. Immunization of man against anthrax using the jet injector method. Zh. Microbiol. Epidemiiol. Immunobiol. 1973; 8: 3
   Google Scholar
• Lesnyak O. T., Saltykov R. A. Preparation of STI-1 anthrax strain exotoxin Zh. Micriobiol. Epidemiol. Immunobiol. 1974; 2: 110
   Google Scholar
• Cherkasskiy B. L. Current problems in the prevention of anthrax. Zh. Microbiol. Epidemiol. Immunobiol. 1979; 8: 3
   Google Scholar
• Coggins C. H. Weapons of Mass Destruction. Mil. Rev. 1963; 42: 43
   Google Scholar
• Twining D. Sverdlovsk anthrax outbreak. Air Force Mag. 1981; 64: 124
   Google Scholar
• Wright G. G., Hedberg M. A., Feinberg R. J. Studies on immunity in anthrax; in vitro elaboration of protective antigen by non proteolytic mutants of Bacillus anthracis. J. Exp. Med. 1951; 93: 523
   PubMed Web of Science ®Google Scholar
• Puziss M., Wright G. G. Studies on immunity in anthrax. X Gel absorbed protective antigen for immunization in man. J. Bacteriol. 1963; 85: 230
   PubMed Web of Science ®Google Scholar
• Albrink W. S., Brooks S. M., Biron R. E., Kopel M. Human inhalation anthrax, a report of three fatal cases. Am. J. Pathol. 1960; 36: 457
   PubMed Web of Science ®Google Scholar
• Rangel Gonzalez R. A.D.A. Bacillus anthracis meningitis. Neurology 1975; 25(6)525
   PubMedGoogle Scholar
• Shanahan R. H., Grifin J. R., von Auersperg A. P. Anthrax meningitis; Report of a case of internal anthrax with recovery. Am. J. Clin. Pathol. 1947; 17: 719
   PubMedGoogle Scholar
• Haight T. H. Anthrax meningitis: Review of literature and report of 2 cases with autopies. Am. J. Med. Sci. 1952; 224: 57
   PubMed Web of Science ®Google Scholar
• Tahernia A. C., Hashemi G. Survival in anthrax meningitis. Pediatrics 1972; 50: 329
   PubMed Web of Science ®Google Scholar
• Levy L. M., Baker N., Meyer Crosland M., Hampton P. J. Anthrax Meningitis in Zimbabwe. Central African J. of Med. 1981; 27: 101
   PubMedGoogle Scholar
• Wright G. Anthrax Toxin in Microbiology 1975, D. Schessinger. American Society for Microbiology, Washington, D.C. 1975; 292
   Google Scholar
• Stephen J. Anthrax Toxin in Pharmacology of Bacterial Toxins, F. Dorner, J. Drews. Pergamon Press, OxfordEngland 1986; 381
   Google Scholar
• Smith H., Keppie J. Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by Bacillus anthracis. Nature 1954; 173: 869
   PubMed Web of Science ®Google Scholar
• Smith H., Tempest D. W., Stanley J. L., Harris-Smith P. W., Gallop R. C. The chemical basis of the virulence of Bacillus anthracis. VII Two components of the anthrax toxin: their relationship to known immunizing agressins. Br. J. Exp. Pathol. 1956; 37: 263
   PubMedGoogle Scholar
• Smith H. The Biochemical Response to Bacterial Injury. The Biochemical Response to Injury, H. B. Stoner, C. J. Threfall. Blackwell Scientific, OxfordEngland 1960; 341
   Google Scholar
• Dalldorf F. G., Beall F. A. Capillary thrombosis as a cause of death in experimental anthrax. Arch. Path. 1967; 83: 154
   PubMedGoogle Scholar
• Dalldorf F. G., Beall F. A., Krigman M. R., Goyer R. A., Livingston H. L. Transcelllular permeability and thrombosis of capillaries in anthrax toxemia. An electron microscopic and biochemical study. Lab. Invest. 1969; 21: 42
   Google Scholar
• Fish D. C., Klein F., Lincoln R. E., Walker J. S., Dobbs J. P. Pathophysiological changes in the rat associated with anthrax toxin. J. Infect. Dis. 1968; 118: 114
   PubMed Web of Science ®Google Scholar
• Vick J. A., Lincoln R. E., Klein F., Mahlandt B. G., Walker J. S., Fish D. C. Neurological and physiological responses of the primate to anthrax toxin. J. Inf. Dis. 1968; 118: 85
   PubMed Web of Science ®Google Scholar
• Kasihiba S., Morilshima T., Kato K., Shima M., Amono T. Leucotoxic substance produced by Bacillus anthracis. Biken's J 1959; 2: 97
   Google Scholar
• Ristroph J. D., Ivins B. E. Elaboration of Bacillus anthracis antigens in a new chemically defined media. Inf. Immun 1983; 39: 483
   PubMedGoogle Scholar
• Leppla S. H. Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations in eucaryotic cells. Proc. Natl. Acad. Sci. USA 1982; 79: 3162
   PubMed Web of Science ®Google Scholar
• Mikesell P., Ivins B. E., Ristroph J. D., Dreier T. M. Evidence for Plasmid-Mediated Toxin Production in Bacilllus anthracis. Inf. Immun. 1983; 39: 371
   PubMed Web of Science ®Google Scholar
• Vodkin M. H., Leppla S. H. Cloning of the Protective antigen Gene of Bacillus anthracis. Cell 1983; 34: 693
   PubMed Web of Science ®Google Scholar
• Mock M., Labruyere E., Glaser P., Danchin A, Ullmann A. Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli. Gene 1988; 64(2)277
   PubMedGoogle Scholar
• Robertson D. L., Leppla S. H. Molecular cloning and expression in Escherichia coli or the lethal factor gene of Bacillus anthracis. Gene 1986; 44(1)71
   PubMedGoogle Scholar
• Cataldi A., Labruyere E., Mock M. Construction and characterization of a protective antigen-deficient Bacillus anthracis strain Mol. Microbiol. 1990; 497: 1111
   Google Scholar
• Singh Y., Chaudhary V. K., Leppla S. H. A deleted variant of Bacillus anthracis protective antigen is non toxic and blocks anthrax toxin action in vivo. J Biol Chem 1989; 264(32)19103
   PubMed Web of Science ®Google Scholar
• Ivins B. E., Welkos S. L. Cloning and expression of Bacillus anthracis protective antigen gene in Bacillus subtilis. Infect.-Immun. 1986; 54: 537
   PubMed Web of Science ®Google Scholar
• Welkos S. L., Lowe J. R., Eden-McCuthan F., Vodkin M., Leppla S. H., Schmidt J. J. Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis. Gene 1988; 69: 287, 300
   PubMed Web of Science ®Google Scholar
• Tippetts M. T., Robertson D. L. Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase. J Bacteriol. 1988; 170(5)263
   Google Scholar
• Robertson D. L., Tipperts M. T., Leppla S. H. Nucleotide sequence of the Bacillus edema factor gene (cya): a calmodulin-dependent adenylate cyclase. Gene 1988; 73(2)363
   PubMedGoogle Scholar
• Bragg Robertson T. S.D.L. Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene 1989; 81(1)45
   PubMedGoogle Scholar
• Pezard C., Berche P., Mock M. Contribution of Individual Toxin Components to Virulence of Bacillus anthracis. Inf Immun 1991; 59: 3472
   PubMed Web of Science ®Google Scholar
• Smith H., Stoner H. B. Anthrax toxin complex. Fed. Proc. 1967; 26: 1554
   PubMedGoogle Scholar
• Green B. D., Battisti L., Koehler T. M., Thorne C. B., Ivins B. E. Demonstration of a Capsule Plasmid in Bacillus anthracis. Infect Immun. 1985; 49: 291
   PubMed Web of Science ®Google Scholar
• Uchida I., Sekizaki T., Hashimoto K., Terakado N. Association of the encapsulation of Bacillus anthracis with a 60megadalton plasmid J. Gen Microbiol. 1985; 131: 363
   PubMedGoogle Scholar
• Uchida I. K., Hashimoto K., Makino S., Sasakawa C., Yoshikawa M., Terakado N. Restriction map of a capsule of plasmid of Bacillus anthracis. Plasmid 1987; 18: 178
   PubMed Web of Science ®Google Scholar
• Makino S., Uchida I., Terakado N., Sasakawa C., Yoshikawa M. Molecular Characterization and Protein Analysis of the cap Region. Which is Essential for Encapsulation in Bacillus anthracis. J. Bacteriol. 1989; 171: 722
   PubMed Web of Science ®Google Scholar
• Stepanov A. S. The Molecular Nature of Bacillus anthracis Toxin. Mol. Gen. Mikrobiol. Virusolog. 1991; 1: 3
   Google Scholar
• Bail O. Unterschungen uberliche and kunstliche Milzbrand-imunitat. A. Bakteriol. Parasitenk. 1904; 37: 270
   Google Scholar
• Cromartie W. J., Bloom W. L., Watson D. W. Studies on infection with Bacillus anthracis I A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J. Inf. Dis. 1947; 80: 1
   Web of Science ®Google Scholar
• Cromartie W. J., Watson D. W., Bloom W. L., Heckly R. J. Studies on infection with Bacillus anthracis. II The immunological and tissue damaging properties of extracts prepared from lesions of B. anthracis infection. J. Inf. Dis. 1947; 80: 14
   PubMed Web of Science ®Google Scholar
• Gladstone G. P. Immunity to anthrax: Protective antigen present in cell free culture filtrates. Br. J. Exp. Pathol. 1946; 27: 394, 418
   PubMed Web of Science ®Google Scholar
• Watson D. W., Cromartie W. J., Bloom W. L., Kegeles G., Heckly R. J. Studies on infection with B. anthracis III. Chemical and immunological properties of the protective antigen in crude extracts of skin lesions of B. anthracis. J. Inf. Dis. 1947; 80: 28
   PubMedGoogle Scholar
• Smith H., Keppie J. Observations on experimental anthrax: Demonstration of a specific lethal factor produced in vivo by B. anthracis. Nature 1954; 173: 869
   PubMed Web of Science ®Google Scholar
• Harris-Smith P. W., Smith H., Keppie J. Production in vitro of the toxin of Bacillus anthracis previously recognized in vivo. J. Gen Micrtobiol. 1958; 19: 91
   PubMedGoogle Scholar
• Wright G. G., Stein J. B. Studies on immunity in anthrax; variation in serum T-agglutinin during anthrax infection in rabbit. J. Exp. Med. 1951; 93: 99
   PubMed Web of Science ®Google Scholar
• Wright G. G., Hedberg M. A., Stein J. B. Studies on immunity in anthrax III. Elaboration of protective antigen in a chemically defined, non protein medium. J. Immunol 1954; 72: 263
   PubMed Web of Science ®Google Scholar
• Stanley J. L., Smith H. The three factors of anthrax toxin: Their immunogenicity and lack of demonstrable enzymatic activity. J. Gen Microbiol. 1962; 31: 329
   Google Scholar
• Beall F. A., Taylor M. J., Thorne C. B. Rapid lethal effect in rats of a third component found upon fractionating the toxin of Bacillur anthracis. J. Bacteriol. 1962; 83: 1274
   PubMed Web of Science ®Google Scholar
• Molnar D. M., Altenbern R. A. Alterations in the Biological Activity of Protective Antigen of Bacillus anthracis Toxin. Proc Soc. Exp. Biol. Med., 114: 294, 196
   PubMedGoogle Scholar
• Raziuddin A., Friedlander A. Anthrax Protective Antigen Receptor: Identification of a Protective Antigen Binding Protein by Chemical Cross Linking. Abstract B301 91 Meeting Amer Soc. Microbiol. 1991; 71
   Google Scholar
• Escuyer V., Collier J. Anthrax Protective Antigen Interacts with a Specific Receptor on the Surface of CHO-K1 Cells. Inf Immun 1991; 59: 3381
   PubMedGoogle Scholar
• Singh Y., Klimpel K. R., Quinn C. P., Chaudhary V. K., Leppla S. H. The carboxyl terminal End of Protective Antigen is Required for Receptor Binding and Anthrax Toxin Activity. J Biol Chem. 1991; 266: 15493
   PubMed Web of Science ®Google Scholar
• Singh Leppla Y., Bhatnagar S. H., Friedlander R. A.M. Internalization and processing of Bacillus anthracis lethal toxin by toxin sensitive and resistant cells. J. Biol Chem. 1989; 264(19)11099
   PubMedGoogle Scholar
• Ezzell J. W., Abshire T. G., Little S., Brown C. Analyses of Bacillus anthracis Vegetative Cell Surface Antigens and of Serum Protease Cleavage of Protective Antigen. Proceedings of the International Workshop on Anthrax, P. C.B. Turnbull. Salisbury Printing Co., WilshireUK, 43–44, Salisbury Med. Bull. No.68
   Google Scholar
• Ezzell J. W., Abshire T. G. Serum Protease Cleavage of Bacillus anthracis Protective Antigen. J. Gen. Microbiol. 1992
   PubMedGoogle Scholar
• Gordon V. M., Young W. W., Lechler S. M., Grey M. C., Leppla S. H., Hewlett E. L. Adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis. Different processes for interaction with and entry into target cells. J. Biol. Chem. 1989; 264: 14792
   PubMedGoogle Scholar
• Leppla S. H. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryoltic cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984; 17: 189
   PubMedGoogle Scholar
• Friedlander A. M. Macrophages are sensitive to anthrax lethal toxin through an acid dependent process. J. Biol. Chem. 1986; 261(16)7123
   PubMed Web of Science ®Google Scholar
• Bhatnagar R., Singh Y., Leppla S. H., Friedlander A. Calcium is Required for the Expression of Anthrax Lethal Toxin Activity in the Macrophagelike. Cell Line 1989; J774A(1)57, 2107
   Google Scholar
• O'Brien J., Friedlander Drier A., Ezzell T. J., Leppla S. Effects of anthrax toxin components on human neutrophils. Infect-Immun. 1985; 47(1)306
   PubMed Web of Science ®Google Scholar
• Wade Wright B. H., Hewlet G. G.E.L., Leppla S. H., Mandell G. L. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils Proc. Soc. Exp. Biol. Med. 1985; 179(2)159
   PubMedGoogle Scholar
• Wright G. G., Mandell G. L. Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and uramyl dipeptide. J. Exp Med. 1986; 164(5)1700
   PubMedGoogle Scholar
• Tafel'shtein E. E., Kalmakov S. V., Chernov A. B., Kondrat'eva A. M., Bashkova V. A. Effect of anthrax toxin on the chemiluminescence of human leucocytes. Biol-Nauki. 1988; 11: 16
   Google Scholar
• Welkos S. L., Keener T. J., Gibbs P. H. Differences in susceptibility of inbred mice to Bacillus anthracis. Inf. Immun. 1986; 51: 795
   PubMed Web of Science ®Google Scholar
• Abalakin V. A. Immunosuspressive action of the lethal toxin of Bacillus anthracis in mice. Zh Mikrobiol. Epidemiol. Immunobiol 1989; 6: 94
   Google Scholar
• Welkos S. L., Trotter R. W., Becker D. M., Nelson G. O. Resistance to the Sterne strain of Banthracis: phagocytic cell responses of resistant and susceptible mice Microb. Pathog. 1989; 7: 15
   Google Scholar
• Ivins B. E., Ezzell Jemski J. W.J., Hedlund K., Ristroph J. D., Leppla S. H. Immunization studies with attenuated strains of Bacillus anthracis. Inf Immun. 1986; 52: 454
   PubMed Web of Science ®Google Scholar
• Ivins B., Welkos S. Recent Advances in the Development of an Improved Human Anthrax Vaccine Eur. J. Epidemiol. 1988; 4: 12
   Google Scholar
• Little S., Knudson G. B. Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig. Inf Immun. 1986; 52: 509
   PubMed Web of Science ®Google Scholar
• Turnbull P. C.B., Broster M. G., Carman J. A., Manchee R. J., Melling J. Development of antibodies to protective antiugen and lethal factor components of anthrax toxin in humans and guinea pigs and the relevance to protective immunity. Inf. Immun. 1986; 52: 356
   PubMed Web of Science ®Google Scholar
• Keppie J., Smith H., Harris-Smith P. W. The chemical basis of the virulence of Bacillus anthracis. III The role of the terminal bacteremia in death of guinea pigs from anthrax. Br. J. Exp. Pathol. 1955; 44: 315
   Google Scholar
• Klein F., Haines B. W., Mahlandt B. G., De Armon I. A., Lincoln R. E. Dual nature of the resistance mehanisms as revealed by studies of anthrax septicemia. J. Bacteriol. 1963; 85: 1032
   PubMedGoogle Scholar
• Sterne M. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort J. Vet. Sci. Anim. Indust 1939; 13: 307
   Google Scholar
• Sterne M., Nichol J., Lambrechts M. C. The effect of large scale immunization against anthrax J. S. Afr. Vet. Med. Assoc. 1942; 13: 53
   Google Scholar
• Marshall E. Sverdlovsk: Anthrax Capital?. Science 1988; 240: 383
   PubMedGoogle Scholar
• Brachman S. P., Gold H., Plotkin S. A., Fekety F. R., Werrin M., Ingraham N. R. Field evaluation of a human anthrax vaccine. Am. J. Public Health 1962; 52: 632
   PubMed Web of Science ®Google Scholar
• Fish D. C., Mahlandt B. G., Dobbs J. P, Lincoln R. E. Purification and properties of in vitro produced anthrax toxin components. J. Bacteriol. 1968; 95: 907
   PubMedGoogle Scholar
• Stanley J. L., Smith H. Purification of Factor I and recognition of a third fan or of the anthrax toxin. J Gen Microbiol. 1961; 26: 49
   PubMedGoogle Scholar
• Mahlandt B. G., Klein F., Lincoln R. E., Haines Jones B. W.W.I., Friedman R. H. Immunological studies of anthrax IV Evalluation of the immunogenicity of three components of anthrax toxin. J. Immunol. 1966; 96: 727
   PubMed Web of Science ®Google Scholar
• Auerbach S., Wright G. C. Studies on immunity in anthrax.VI Immunizing activity of protective antigen against various strains of Bacillus anthracis. J. Immunol 1955; 75: 129
   PubMed Web of Science ®Google Scholar
• Ward M. K., McGann V. G., Hogge A. L., Huff M. L., Kanode R. G., Roberts E. O. Studies on anthrax infections in immunized quinea pigs. J. Inf. Dis. 1965; 115: 59
   PubMed Web of Science ®Google Scholar
• Brachman P. S., Plotkin S. A., Bumford F. H., Atchinson M. N. An epidemic of inhalation anthrax: The first in the twentieth century.II Epidemiology. Am. J. Hyg. 1960; 72: 6
   PubMed Web of Science ®Google Scholar
• Abalakin V. A., Sergeeva L. V., Cherkasova T. D. Purification and characteristics of a protective factor from Bacillus anthracis toxin. Biokhimii 1988; 53: 282
   Google Scholar
• Quinn C. P., Shone C. C., Turnbull P. C., Melling J. Purification of anthrax toxin components by high performance anion exchange, gel filtration, and hydrophobic interaction chromatography. Biochem. J. 1988; 252: 753
   PubMedGoogle Scholar
• Larson D. K., Calton G. J., Little S. F., Leppla S. H., Burnett J. W. Separation of three exotoxic factors of Bacillus anthracis by sequential immunosorbent. Chromatography 1988; 26: 913
   Google Scholar
• Welkos S. L., Friedlander A. M. Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice. Microb-Pathog. 1988; 5: 127
   PubMed Web of Science ®Google Scholar
• Ivins B. E., Welkos S. L., Knudson G. B., Little S. F. Immunization against Anthrax with Aromatic Compound Dependent (Aro-) Mutants of Bacillus anthracis and with Recombinant Strains of Bacillus subtilis That Produce Anthrax Protective Antigen. Infect Immun. 1990; 58: 303
   PubMed Web of Science ®Google Scholar
• Iacono-Connors L. C., Welkos Ivins S. L.B.E., Dalrymple J. M. Protection against Anthrax with Recombinant Virus Expressed Protective Antigen in Experimental Animals. Infect Immun. 1991; 59: 1961
   PubMed Web of Science ®Google Scholar
• Turnbull P. C.B. Anthrax vaccines:past, present and future. Vaccine 1991; 9: 533
   PubMed Web of Science ®Google Scholar
• Blaustein Koehler R. O., Collier T. M.R.J., Finlelstein A. Anthrax toxin: channel forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl Acad Sci m 1989; 86: 2209
   PubMedGoogle Scholar
• Welkos S., Ivins B. Plasmid pX02-associated Differences in Virulence of B. 1991, anthracis Strains Vollum1B and Ames. Abstract B 298 ASM
   Google Scholar